Octostar, a company developing AI-powered intelligence software for national security, law enforcement, and financial institutions, has secured a €6.1 million seed extension.
Octostar, a company developing AI-powered intelligence software for national security, law enforcement, and financial institutions, has secured a €6.1 million seed extension.
Teybridge Capital Europe, a fintech company based in Dublin, has announced plans to invest €5.2 million over the next three years to expand its operations in the United Kingdom.
Biocaptiva, a biotechnology company based in Edinburgh, has secured £1.58 million in new funding to expand the development of its liquid biopsy sample preparation technology.
Galway-based MedTech company Neurent Medical has secured €62.5 million ($74 million) in an oversubscribed Series C funding round to accelerate commercial growth, expand clinical evidence and advance its product and indication pipeline.
ArrayPatch Ltd, a biotech company developing microneedle-based therapeutics, has completed the first close of its €3 million seed funding round to advance ITZ-DerMap™, its lead treatment candidate for onychomycosis, commonly known as nail fungus.
Aerska, a biotechnology company developing RNA-based medicines for central nervous system diseases, has raised $39M in a Series A round to accelerate development of its proprietary brain shuttle platform.
TeamFeePay, a Belfast-based sports technology company, has raised £9M in an equity funding round to support expansion into new markets and planned team growth. The funding will be used to scale operations across the UK, Ireland, and Europe.
Equal1, a quantum semiconductor company, has secured $60 million in funding to accelerate the development of scalable quantum computers built on standard silicon processes and to advance deployment of its data centre–ready Bell-1 quantum server.
